Philip Kuo, MD
Allergy & Immunology · Kailua, HINPI 1164459327
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (58.6%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. GE HealthCare accounts for 68.0% of it on its own, with 26 other manufacturers making up the rest. Reporting peaked in 2024 at $19,859 and has fallen 94.1% since, to $1,173 in 2025.
Across 389 payments — averaging $70.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GE HealthCare$19K
- GSK$3K
- AstraZeneca$2K
- Regeneron Healthcare Solutions, Inc.$2K
- Sanofi$487
- Genentech USA, Inc.$413
- plus $1K from 21 others
Across 2 payments — averaging $407.05 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis Pharma AG$814
What the payments were for
- Consulting fees$1,4505%
- Speaking & faculty fees$16,01659%
- Travel & lodging$1,1154%
- Food & beverage$8,72932%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GE HealthCare | 9 | $18,581 |
| GSK | 151 | $2,574 |
| AstraZeneca | 79 | $2,260 |
| Regeneron Healthcare Solutions, Inc. | 61 | $1,643 |
| Sanofi | 19 | $487 |
| Genentech USA, Inc. | 20 | $413 |
| Novo Nordisk | 14 | $301 |
| Lilly USA, LLC | 5 | $233 |
| Pharming Healthcare, Inc. | 1 | $125 |
| LEO Pharma Inc. | 6 | $124 |
| Boehringer Ingelheim | 4 | $99 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $52 |
| Merck | 2 | $43 |
| CSL Behring | 2 | $42 |
| Grifols USA, LLC | 2 | $41 |
| AbbVie | 1 | $35 |
| Ionis Pharmaceuticals, Inc. | 1 | $35 |
| Radius Health, Inc. | 1 | $31 |
| Novartis | 1 | $26 |
| Esperion Therapeutics, Inc. | 1 | $26 |
| Amgen | 1 | $26 |
| X4 Pharmaceuticals, Inc. | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Cycle Pharmaceuticals Inc | 1 | $19 |
| Biohaven Pharmaceuticals, Inc. | 1 | $17 |
| Hikma Pharmaceuticals USA | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few allergy & immunology providers in Hawaiito place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 19 | $21,826 |
| Azelastine Hcl | 45 | $2,087 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 29 | $871 |
| Fluticasone Propionate | 38 | $739 |
| Proair RespiclickAlbuterol Sulfate | 11 | $732 |
| Triamcinolone Acetonide | 28 | $252 |
| Montelukast Sodium | 11 | $223 |
| Prednisone | 21 | $77 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta | $2,574 | $21,82619 claims |
| Teva Pharmaceuticals USA, Inc.Proair Respiclick | $20 | $73211 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few allergy & immunology providers in Hawaiion file to place this against a meaningful peer group, so we don't.
Other allergy & immunology in Kailua
- Philip KuoKailua$9K
- Marina OstroukhovaHonolulu$158K
- Abigail HaradaHonolulu$8K
- Kelly ShibuyaHonolulu$7K
- Akila SreedharanHonolulu$6K
- Richard AndoHonolulu$5K
- Matthew LauHonolulu$3K
- Allan WangKailua Kona$2K
- Jennifer MbuthiaHonolulu$2K
- Faye TachibanaAiea$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.